A wide range of cost-effective animal models, from Drosophila to non-human primates, from knockout models to different disease models, are released.
In a pioneering effort to revolutionize life science research, a wide range of cost-effective animal disease models, from Drosophila to non-human primates, from knockout models to different disease models, are released. These groundbreaking...
Protheragen offers a variety of CAR-T cell therapy services, including personalized CAR-T cell analysis and therapy regimens based on a variety of disease models.
Protheragen is an advanced CAR-T cell therapy service provider. With its extensive experience in cell therapy development and EndureCART™ technology platform, Protheragen provides investigators a wide range of disease models to...
Protheragen, a leading biotechnology company specializing in advanced research services, announces its comprehensive suite of solutions designed to accelerate research and treatment development for Systemic Mitochondrial Disease. The company's specialized services address the complex challenges associated with these rare but devastating disorders.
Systemic Mitochondrial Disease refers to...
Protheragen, a leading biotechnology company specializing in innovative genetic solutions, announced the expansion of its comprehensive Adeno-Associated Virus (AAV) Vector Platform services to meet the growing demands of gene therapy research and development.
Adeno-associated virus (AAV) is a non-enveloped virus that can transport DNA to target cells through genetic engineering, and...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Russian
Romaian
Portuguese (Brazil)
Greek
